tiprankstipranks
CytomX Therapeutics price target lowered to $3.25 from $3.50 at Piper Sandler
PremiumThe FlyCytomX Therapeutics price target lowered to $3.25 from $3.50 at Piper Sandler
4M ago
CytomX Therapeutics Reports Q3 Progress and Growth
Premium
Company Announcements
CytomX Therapeutics Reports Q3 Progress and Growth
4M ago
CytomX Therapeutics reports Q3 EPS 7c, consensus (17c)
Premium
The Fly
CytomX Therapeutics reports Q3 EPS 7c, consensus (17c)
4M ago
CTMX Earnings this Week: How Will it Perform?
PremiumPre-EarningsCTMX Earnings this Week: How Will it Perform?
7M ago
CytomX Therapeutics Appoints Chris Ogden as New CFO
Premium
Company Announcements
CytomX Therapeutics Appoints Chris Ogden as New CFO
8M ago
CytomX Therapeutics promotes Chris Ogden to CFO
Premium
The Fly
CytomX Therapeutics promotes Chris Ogden to CFO
8M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
10M ago
Wedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a data
Premium
The Fly
Wedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a data
10M ago
CytomX Therapeutics upgraded to Outperform from Neutral at Wedbush
Premium
The Fly
CytomX Therapeutics upgraded to Outperform from Neutral at Wedbush
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100